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Abstract 
A 68-year-old man developed bilateral sequential non-arteritic anterior ischaemic optic 
neuropathy, each episode occurring with a close temporal relationship to influenza 
vaccination. © 2014 S. Karger AG, Basel 
Case Report 
A 68-year-old man reported a 2-day history of reduced visual acuity 10 days after re-
ceiving the influenza vaccine. He reported no constitutional symptoms. His medical history 
included type 2 diabetes mellitus, previous transurethral resection of the prostate and 
erectile dysfunction treated with tadalafil. His ocular history included hypermetropia and 
left mild anisometropic amblyopia, with previous best-corrected visual acuities of 6/5 in his 
right eye and 6/12 in his left eye.  
On examination, his visual acuities were 6/5 in the right eye and 6/60 in the left eye, 
improving to 6/36 with a pinhole. His colour vision was normal, with an Ishihara of 17/17 
bilaterally. There was no relative afferent pupillary defect and no pain or diplopia on eye 
movements. Fundoscopy revealed bilateral crowded discs with evidence of disc swelling in 
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the left eye. 24-2 Humphrey visual field testing identified an altitudinal visual field defect in 
the left eye. 
The patient was diagnosed with anterior ischaemic optic neuropathy (AION) and labora-
tory studies were obtained to exclude giant cell arteritis. He had a normal full blood count, C-
reactive protein of <4 mg/dl, and an erythrocyte sedimentation rate of 3 mm/h as well as 
normal blood pressure. The only abnormal finding was a raised cholesterol level of 6.1 
mmol/l (normal, <5 mmol/l). Having refined the diagnosis to non-arteritic (NA) AION, he 
was commenced on aspirin 75 mg once daily, although the evidence for this is mixed [1, 2]. 
He also ceased the use of tadalafil. Subsequent MRI of his brain and orbits proved normal. 
Over the next 3 months, his visual acuity in the left eye recovered to 6/36 with a persis-
tent field defect. However, the following year, 6 days after receiving the influenza vaccine, he 
returned with a new-onset visual field defect in his right eye. His visual acuity remained 
good at 6/5 in the right eye and 6/36 in the left eye. Ocular findings were again normal apart 
from a swelling of the superior disc margin in the right eye, but 24-2 Humphrey visual field 
testing revealed an inferior altitudinal visual field defect in the right eye (fig. 1, fig. 2). 
Laboratory studies again excluded giant cell arteritis but, given the temporal relation to 
his influenza vaccination, an immune-mediated component of the aetiology was considered, 
and he was treated with high-dose corticosteroid in the form of 80 mg prednisolone once 
daily. This was tapered off over 3 months and his visual acuity remained 6/5 in the right eye, 
although his inferior altitudinal visual field defect persisted. 
Discussion 
Ocular complications following influenza vaccination are rare but they have been rec-
orded. Optic neuritis is well-described [3–5] and the proposed mechanism is immune-
mediated optic nerve demyelination [4], which may be unilateral or bilateral. The majority of 
patients recover substantially without treatment.  
Our case differs from the majority in that the clinical findings are consistent with a 
diagnosis of AION: an altitudinal visual field defect associated with segmental disc swelling. 
To our knowledge, there has been only 1 previous case reported in the literature of NA-AION 
following influenza vaccination [6]. In this case, the reported visual loss was bilateral and 
associated with systemic symptoms and raised serum inflammatory markers. The authors 
proposed an immune complex-mediated vasculopathy as a likely mechanism. Here, we 
report sequential NA-AION in one and the same patient, each event occurring with a close 
temporal relation to influenza vaccination.  
Our patient was over 65, had a history of diabetes mellitus and was hypermetropic with 
small optic discs and taking tadalafil, all of which are known or potential risk factors for NA-
AION [7, 8]. However, the close temporal relationship to vaccination does suggest the 
possibility of an inflammatory or immune-mediated element to the timing of its develop-
ment. Nevertheless, the cumulative incidence of second-eye involvement in NA-AION is 18% 
at 1 year and 25% at 3 years [9]. Thus, our case probably represents a chance occurrence, 
especially as there is some evidence that within-season influenza vaccination leads to a 
reduced incidence of stroke and other cardiovascular events [10]. 
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Fig. 1. a Disc swelling in the superior segment of the disc, and b associated altitudinal field defect in the 
right eye following the second influenza vaccination. 
 
 
 
Fig. 2. Fundus photography at the same time as figure 1 indicates resolution of disc swelling in in the left 
eye (a), but a persistent inferior visual field defect (b). 
 
